Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Concentrations of 6-thioguanine nucleotide correlate with trough levels of infliximab in patients with inflammatory bowel disease on combination therapy.
Yarur AJ, Kubiliun MJ, Czul F, Sussman DA, Quintero MA, Jain A, Drake KA, Hauenstein SI, Lockton S, Deshpande AR, Barkin JS, Singh S, Abreu MT. Yarur AJ, et al. Among authors: drake ka. Clin Gastroenterol Hepatol. 2015 Jun;13(6):1118-24.e3. doi: 10.1016/j.cgh.2014.12.026. Epub 2015 Jan 3. Clin Gastroenterol Hepatol. 2015. PMID: 25562796
Early immune factors associated with the development of post-acute sequelae of SARS-CoV-2 infection in hospitalized and non-hospitalized individuals.
Leung JM, Wu MJ, Kheradpour P, Chen C, Drake KA, Tong G, Ridaura VK, Zisser HC, Conrad WA, Hudson N, Allen J, Welberry C, Parsy-Kowalska C, Macdonald I, Tapson VF, Moy JN, deFilippi CR, Rosas IO, Basit M, Krishnan JA, Parthasarathy S, Prabhakar BS, Salvatore M, Kim CC. Leung JM, et al. Among authors: drake ka. Front Immunol. 2024 Jan 22;15:1348041. doi: 10.3389/fimmu.2024.1348041. eCollection 2024. Front Immunol. 2024. PMID: 38318183 Free PMC article.
Distinct temporal trajectories and risk factors for Post-acute sequelae of SARS-CoV-2 infection.
Chen C, Parthasarathy S, Leung JM, Wu MJ, Drake KA, Ridaura VK, Zisser HC, Conrad WA, Tapson VF, Moy JN, deFilippi CR, Rosas IO, Prabhakar BS, Basit M, Salvatore M, Krishnan JA, Kim CC. Chen C, et al. Among authors: drake ka. Front Med (Lausanne). 2023 Oct 16;10:1227883. doi: 10.3389/fmed.2023.1227883. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37908849 Free PMC article.
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 Progressors.
Drake KA, Talantov D, Tong GJ, Lin JT, Verheijden S, Katz S, Leung JM, Yuen B, Krishna V, Wu MJ, Sutherland AM, Short SA, Kheradpour P, Mumbach MR, Franz KM, Trifonov V, Lucas MV, Merson J, Kim CC; PRESCO Study Group. Drake KA, et al. Clin Immunol. 2023 Nov;256:109808. doi: 10.1016/j.clim.2023.109808. Epub 2023 Oct 16. Clin Immunol. 2023. PMID: 37852344 Free article.
Multi-omic Profiling Reveals Early Immunological Indicators for Identifying COVID-19 Progressors.
Drake KA, Talantov D, Tong GJ, Lin JT, Verheijden S, Katz S, Leung JM, Yuen B, Krishna V, Wu MJ, Sutherland A, Short SA, Kheradpour P, Mumbach M, Franz K, Trifonov V, Lucas MV, Merson J, Kim CC; PRESCO Study Group. Drake KA, et al. bioRxiv [Preprint]. 2023 May 26:2023.05.25.542297. doi: 10.1101/2023.05.25.542297. bioRxiv. 2023. Update in: Clin Immunol. 2023 Nov;256:109808. doi: 10.1016/j.clim.2023.109808 PMID: 37292797 Free PMC article. Updated. Preprint.
34 results